
Sudarshan Pharma: 18th AGM Proceedings Summary
Sudarshan Pharma Industries Limited held its 18th Annual General Meeting (AGM) on Tuesday, September 22, 2026, at 3:00 p.m. via Video Conferencing/Other Audio Visual Means. Mr. Hemal Mehta, Chairman & Managing Director, chaired the meeting. Key agenda items transacted included the adoption of the audited standalone and consolidated financial statements for the financial year ended March 31, 2026. Additionally, members considered and approved the re-appointment of Dr. Anil Ghogare as a director. The company facilitated e-voting for members, with Mr. Vishal Mansukha appointed as the Scrutinizer. The consolidated results of the voting will be declared within two working days of the AGM's conclusion and will be communicated to BSE Limited and published on the company's website.
Key Highlights
- 18th AGM held on September 22, 2026, via VC/OAVM.
- Audited financial statements for FY2025-26 were adopted.
- Dr. Anil Ghogare re-appointed as a director.
- E-voting facility provided; results to be declared within two days.
Price Impact
More from SUDARSHAN